---
title: "MapLight Therapeutics Announces $150 Million Private Placement Financing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295807484.md"
description: "MapLight Therapeutics (MPLT) announced a $150 million private placement financing on August 13, 2026. The clinical-stage biopharmaceutical company partnered with institutional and accredited investors via a securities purchase agreement to raise capital before fees and expenses. This round includes both new and existing institutional supporters."
datetime: "2026-08-13T13:11:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295807484.md)
  - [en](https://longbridge.com/en/news/295807484.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295807484.md)
generator: "portal-rs"
---

# MapLight Therapeutics Announces $150 Million Private Placement Financing

In a recent announcement on August 13, 2026, MapLight Therapeutics, Inc., listed on Nasdaq as MPLT, has disclosed a new initiative. The clinical-stage biopharmaceutical company, with headquarters in both San Francisco and Boston, aims to enhance the quality of life for individuals dealing with severe central nervous system disorders. Through a securities purchase agreement, they have partnered with institutional and accredited investors for a private placement financing (the “PIPE”), resulting in a substantial gross profit of about $150 million. This total amount is before any deductions for placement agent fees and anticipated offering expenses. The financing round is notably backed by a combination of fresh investors as well as existing institutional supporters.

### Related Stocks

- [MPLT.US](https://longbridge.com/en/quote/MPLT.US.md)

## Related News & Research

- [Catalyst4 acquires $50.07 million of MapLight Therapeutics common shares](https://longbridge.com/en/news/296276892.md)
- [Segal Trials Reinforces Leadership in Acute Schizophrenia Research Following Participation in MapLight Therapeutics’ Phase 2 ZEPHYR Study](https://longbridge.com/en/news/296635926.md)
- [Diversify Advisory Services LLC Buys New Holdings in Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/296585791.md)
- [BlackRock Inc. Makes New $1.08 Billion Investment in Corcept Therapeutics Incorporated $CORT](https://longbridge.com/en/news/296675400.md)
- [Corcept Therapeutics (NASDAQ:CORT) Director James Wilson Sells 10,000 Shares of Stock](https://longbridge.com/en/news/296332659.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**